Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses.

Merten OW, Kallel H, Manuguerra JC, Tardy-Panit M, Crainic R, Delpeyroux F, Van der Werf S, Perrin P.

Cytotechnology. 1999 Jul;30(1-3):191-201. doi: 10.1023/A:1008021317639.

2.

Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania.

Combiescu M, Guillot S, Persu A, Baicus A, Pitigoi D, Balanant J, Oprisan G, Crainic R, Delpeyroux F, Aubert-Combiescu A.

Arch Virol. 2007;152(4):727-38. Epub 2007 Jan 3.

PMID:
17195957
3.

Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples.

Romanenkova NI, Guillot S, Rozaeva NR, Crainic R, Bichurina MA, Delpeyroux F.

J Clin Microbiol. 2006 Nov;44(11):4077-84. Epub 2006 Sep 6.

4.

New PCR test that recognizes all human prototypes of enterovirus: application for clinical diagnosis.

Bourlet T, Caro V, Minjolle S, Jusselin I, Pozzetto B, Crainic R, Colimon R.

J Clin Microbiol. 2003 Apr;41(4):1750-2.

5.

Genetic recombination in wild-type poliovirus.

Dahourou G, Guillot S, Le Gall O, Crainic R.

J Gen Virol. 2002 Dec;83(Pt 12):3103-10.

PMID:
12466487
6.

Natural genetic recombination between co-circulating heterotypic enteroviruses.

Oprisan G, Combiescu M, Guillot S, Caro V, Combiescu A, Delpeyroux F, Crainic R.

J Gen Virol. 2002 Sep;83(Pt 9):2193-200.

PMID:
12185273
7.

Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients.

Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Faure G, Crainic R, Budkowska A.

J Virol. 2001 Sep;75(17):8240-50.

8.

Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.

Cuervo NS, Guillot S, Romanenkova N, Combiescu M, Aubert-Combiescu A, Seghier M, Caro V, Crainic R, Delpeyroux F.

J Virol. 2001 Jul;75(13):5740-51.

9.

Molecular strategy for 'serotyping' of human enteroviruses.

Caro V, Guillot S, Delpeyroux F, Crainic R.

J Gen Virol. 2001 Jan;82(Pt 1):79-91.

PMID:
11125161
10.

[Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].

Delpeyroux F, Guillot S, Szendröi A, Balanant J, Caro V, Cuervo N, Chevaliez S, Dahourou G, Crainic R.

Bull Soc Pathol Exot. 2000 Jul;93(3):193-7. Review. French.

PMID:
11030056
11.

Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel.

Shulman LM, Manor Y, Handsher R, Delpeyroux F, McDonough MJ, Halmut T, Silberstein I, Alfandari J, Quay J, Fisher T, Robinov J, Kew OM, Crainic R, Mendelson E.

J Clin Microbiol. 2000 Oct;38(10):3729-34.

12.

Natural genetic exchanges between vaccine and wild poliovirus strains in humans.

Guillot S, Caro V, Cuervo N, Korotkova E, Combiescu M, Persu A, Aubert-Combiescu A, Delpeyroux F, Crainic R.

J Virol. 2000 Sep;74(18):8434-43.

13.

Molecular epidemiology of poliovirus infection in Tunisia.

Triki H, Bahri O, Guillot S, van der Avoort HG, Sassi JB, Arrouji A, Arrouji Z, Slim A, Crainic R, Dellagi K.

J Med Microbiol. 1999 Jun;48(6):569-76.

PMID:
10359306
14.

Antigenic and molecular characterization of wild type 1 poliovirus causing outbreaks of poliomyelitis in Albania and neighboring countries in 1996.

Fiore L, Genovese D, Diamanti E, Catone S, Ridolfi B, Ibrahimi B, Konomi R, van der Avoort HG, Hovi T, Crainic R, Simeoni P, Amato C.

J Clin Microbiol. 1998 Jul;36(7):1912-8.

15.

Activation of the envelope proteins by a metalloproteinase enables attachment and entry of the hepatitis B virus into T-lymphocyte.

Budkowska A, Maillard P, Theret N, Groh F, Possehl C, Topilko A, Crainic R.

Virology. 1997 Oct 13;237(1):10-22.

16.

Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site.

Sawyer LA, Wood D, Ferguson M, Crainic R, Beuvery EC, McInnis J, Albrecht P.

Biologicals. 1997 Sep;25(3):299-306.

PMID:
9324998
17.

Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors.

Merten OW, Wu R, Couvé E, Crainic R.

Cytotechnology. 1997 Nov;25(1-3):35-44. doi: 10.1023/A:1007999313566.

18.

Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.

Georgescu MM, Balanant J, Macadam A, Otelea D, Combiescu M, Combiescu AA, Crainic R, Delpeyroux F.

J Virol. 1997 Oct;71(10):7758-68.

19.

Random selection: a model for poliovirus infection of the central nervous system.

Georgescu MM, Balanant J, Ozden S, Crainic R.

J Gen Virol. 1997 Aug;78 ( Pt 8):1819-28.

PMID:
9266975
20.

Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants.

Triki H, Abdallah MV, Ben Aissa R, Bouratbine A, Ben Ali Kacem M, Bouraoui S, Koubaa C, Zouari S, Mohsni E, Crainic R, Dellagi K.

Vaccine. 1997 Jul;15(10):1123-9.

PMID:
9269056
21.

Elucidating mechanisms of thermostabilization of poliovirus by D2O and MgCl2.

Chen CH, Wu R, Roth LG, Guillot S, Crainic R.

Arch Biochem Biophys. 1997 Jun 1;342(1):108-16.

PMID:
9185619
22.

The replacement of water with deuterium oxide significantly improves the thermal stability of the oral poliovirus vaccine.

Crainic R, Wu R, Otelea D, Georgescu MM, Delpeyroux F, Guillot S, Balanant J, Tardy-Panit M.

Dev Biol Stand. 1996;87:161-6.

PMID:
8854013
23.

Comparative study of five methods for intratypic differentiation of polioviruses.

van der Avoort HG, Hull BP, Hovi T, Pallansch MA, Kew OM, Crainic R, Wood DJ, Mulders MN, van Loon AM.

J Clin Microbiol. 1995 Oct;33(10):2562-6.

24.

Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.

Georgescu MM, Tardy-Panit M, Guillot S, Crainic R, Delpeyroux F.

J Virol. 1995 Sep;69(9):5278-86.

25.

Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus.

Georgescu MM, Delpeyroux F, Crainic R.

J Gen Virol. 1995 Sep;76 ( Pt 9):2343-8.

PMID:
7561775
26.

Thermostabilization of live virus vaccines by heavy water (D2O).

Wu R, Georgescu MM, Delpeyroux F, Guillot S, Balanant J, Simpson K, Crainic R.

Vaccine. 1995 Aug;13(12):1058-63.

PMID:
7491812
27.

Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope.

Wien MW, Filman DJ, Stura EA, Guillot S, Delpeyroux F, Crainic R, Hogle JM.

Nat Struct Biol. 1995 Mar;2(3):232-43.

PMID:
7539711
28.

High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.

Georgescu MM, Delpeyroux F, Tardy-Panit M, Balanant J, Combiescu M, Combiescu AA, Guillot S, Crainic R.

J Virol. 1994 Dec;68(12):8089-101.

30.

Evolution and polymorphism of poliovirus genomes.

Crainic R, Kew O.

Biologicals. 1993 Dec;21(4):379-84. Review.

PMID:
8024754
31.

Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.

Furione M, Guillot S, Otelea D, Balanant J, Candrea A, Crainic R.

Virology. 1993 Sep;196(1):199-208.

PMID:
8102826
32.

Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.

Otelea D, Guillot S, Furione M, Combiescu AA, Balanant J, Candrea A, Crainic R.

Dev Biol Stand. 1993;78:33-8.

PMID:
8099049
33.

Molecular epidemiology of type 1 polioviruses isolated in Israel and defined by restriction fragment length polymorphism assay.

Vonsover A, Handsher R, Neuman M, Guillot S, Balanant J, Rudich H, Mendelson E, Swartz T, Crainic R.

J Infect Dis. 1993 Jan;167(1):199-203.

PMID:
8093362
34.

The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay.

Balanant J, Guillot S, Candrea A, Delpeyroux F, Crainic R.

Virology. 1991 Oct;184(2):645-54.

PMID:
1679577
35.

Antibodies may act synergistically or additively with interferon to inhibit poliovirus.

Langford MP, Crainic R, Vrijsen R, Wimmer E.

Microb Pathog. 1991 Jun;10(6):419-27.

PMID:
1665535
36.
37.

Characterization of persistent poliovirus mutants selected in human neuroblastoma cells.

Pelletier I, Couderc T, Borzakian S, Wyckoff E, Crainic R, Ehrenfeld E, Colbere-Garapin F.

Virology. 1991 Feb;180(2):729-37.

PMID:
1846495
38.
39.

Poliovirus permissivity and specific receptor expression on human endothelial cells.

Couderc T, Barzu T, Horaud F, Crainic R.

Virology. 1990 Jan;174(1):95-102.

PMID:
2152997
40.

Molecular pathogenesis of neural lesions induced by poliovirus type 1.

Couderc T, Christodoulou C, Kopecka H, Marsden S, Taffs LF, Crainic R, Horaud F.

J Gen Virol. 1989 Nov;70 ( Pt 11):2907-18.

PMID:
2555432
41.

Persistent poliovirus infection of human neuroblastoma cells.

Colbère-Garapin F, Christodoulou C, Crainic R, Pelletier I.

Proc Natl Acad Sci U S A. 1989 Oct;86(19):7590-4.

42.

Molecular pathogenesis of type 2 poliovirus in mice.

Couderc T, Guinguene B, Horaud F, Aubert-Combiescu A, Crainic R.

Eur J Epidemiol. 1989 Sep;5(3):270-4.

PMID:
2551721
43.

Expression of a poliovirus type 1 neutralization epitope on a diphtheria toxin fusion protein.

Phalipon A, Crainic R, Kaczorek M.

Vaccine. 1989 Apr;7(2):132-6.

PMID:
2473577
44.

An insight into poliovirus biology.

Crainic R, Couderc T, Martin A, Wychowski C, Girard M, Horaud F.

Adv Exp Med Biol. 1989;257:61-6. Review. No abstract available.

PMID:
2482671
45.

Addition of a foreign oligopeptide to the major capsid protein of poliovirus.

Colbère-Garapin F, Christodoulou C, Crainic R, Garapin AC, Candrea A.

Proc Natl Acad Sci U S A. 1988 Nov;85(22):8668-72.

46.

Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.

Martin A, Wychowski C, Couderc T, Crainic R, Hogle J, Girard M.

EMBO J. 1988 Sep;7(9):2839-47.

47.

Construction and characterization of hybrid hepatitis B antigen particles carrying a poliovirus immunogen.

Delpeyroux F, Crainic R, Blondel B, Horaud F, Van der Werf S, Girard M, Lagarde D, Mazert MC, Streeck RE.

Biochimie. 1988 Aug;70(8):1065-73.

PMID:
2465786
48.
49.

Construction of a chimaeric type 1/type 2 poliovirus by genetic recombination.

Martin A, Wychowski C, Benichou D, Crainic R, Girard M.

Ann Inst Pasteur Virol. 1988 Jan-Mar;139(1):79-88.

PMID:
2849960
50.

Present knowledge of poliovirus and perspectives for future vaccines.

Crainic R, Blondel B.

Dev Biol Stand. 1987;66:377-83.

PMID:
3034705

Supplemental Content

Loading ...
Support Center